Patent ID: 11971418
Assignee: MESO SCALE TECHNOLOGIES, LLC.
Field: Measurement (Instruments)
Classification: CPC G | IPC G

Claim 0:
1. A method of detecting glomerulonephritis (GN) in a patient, comprising:
(a) receiving a comparison of a normal control level of biomarkers versus a level of at least three or more of a plurality of biomarkers in a test sample obtained from a patient, said plurality of biomarkers selected from (i) a first group consisting of aGST, IL-6, CHGA, E-Cadherin, Timp-1, TNF-RI, and TNF-RII, and (ii) a second group consisting of EGF, UMOD, and SERPINB3, wherein at least one of said three biomarkers is a biomarker from the second group and at least one of said three biomarkers is a biomarker from the first group;
(b) evaluating from said comparison that the patient has GN; and
(c) administering a treatment regimen based on said evaluating step (b), wherein said treatment regimen comprises one or more of diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor agonists, antibiotics, corticosteroids, immunosuppressants, fish oil supplements, or plasmapheresis.